The impact of metabolic dysfunction-associated fatty liver disease on the prognosis of patients with hepatocellular carcinoma after radical resection.
Hepatobiliary & pancreatic diseases international : HBPD INT（2022）
摘要
MAFLD improves RFS rate in HCC patients with radical resection, but is not an independent protective factor and not associated with OS rate.
更多查看译文
关键词
Hepatocellular carcinoma,Metabolic dysfunction-associated fatty liver disease,Prognosis,Radical resection
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要